Cargando…

Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy

BACKGROUND: Clinical studies have suggested that prostate health index (phi) outperforms prostate-specific antigen (PSA) tests in prostate cancer detection. The cost-effectiveness of phi with different cutoffs is poorly understood in the context of decision making for prostate biopsy. METHODS: In a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Da, Yang, Xiaoqun, Wu, Yishuo, Lin, Xiaoling, Xu, Danfeng, Na, Rong, Xu, Jianfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732507/ https://www.ncbi.nlm.nih.gov/pubmed/33330035 http://dx.doi.org/10.3389/fonc.2020.565382

Ejemplares similares

Age-Specific Prostate Specific Antigen Cutoffs for Guiding Biopsy Decision in Chinese Population
por: Na, Rong, et al.
Publicado: (2013)

A Germline Variant at 8q24 Contributes to the Serum p2PSA Level in a Chinese Prostate Biopsy Cohort
por: Lin, Xiaoling, et al.
Publicado: (2021)

The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy
por: Ruan, Xiaohao, et al.
Publicado: (2023)

Genetic polymorphisms at 19q13.33 are associated with [−2]proPSA (p2PSA) levels and provide additional predictive value to prostate health index for prostate cancer
por: Huang, Da, et al.
Publicado: (2021)

Outcomes and Trends of Prostate Biopsy for Prostate Cancer in Chinese Men from 2003 to 2011
por: Na, Rong, et al.
Publicado: (2012)

Is Additional Systematic Biopsy Necessary in All Initial Prostate Biopsy Patients With Abnormal MRI?
por: Cheng, Xueqing, et al.
Publicado: (2021)

Modified Predictive Model and Nomogram by Incorporating Prebiopsy Biparametric Magnetic Resonance Imaging With Clinical Indicators for Prostate Biopsy Decision Making
por: Pan, Jin-feng, et al.
Publicado: (2021)

Clinically available RNA profiling tests of prostate tumors: utility and comparison
por: Na, Rong, et al.
Publicado: (2016)

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
por: Andreas, Darian, et al.
Publicado: (2016)

Role of Prostate-Specific Antigen Change Ratio at Initial Biopsy as a Novel Decision-Making Marker for Repeat Prostate Biopsy
por: Lee, Jung Gon, et al.
Publicado: (2012)

Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
por: Jin, Xin, et al.
Publicado: (2022)

Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis
por: Hupe, Marie Christine, et al.
Publicado: (2018)

Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making
por: Mandel, Philipp, et al.
Publicado: (2021)

Development and validation of a predictive model for diagnosing prostate cancer after transperineal prostate biopsy
por: Ren, Wenming, et al.
Publicado: (2022)

Prostate Health Index Density Outperforms Prostate Health Index in Clinically Significant Prostate Cancer Detection
por: Chiu, Shih-Ting, et al.
Publicado: (2021)

Metastasectomy for rectal wall seeding of prostate adenocarcinoma after transrectal prostate biopsy
por: DiLizia, E Matthew, et al.
Publicado: (2020)

The Accuracy of Transrectal Ultrasound-Guided Biopsy for Decision Making in Prostate Cancer
por: Ghadian, Ali Reza, et al.
Publicado: (2014)

Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs
por: Tomer, Anirudh, et al.
Publicado: (2019)

Plasma genistein and risk of prostate cancer in Chinese population
por: Wu, Yishuo, et al.
Publicado: (2015)

Application of single-point prostate biopsy in elderly patients with highly suspected prostate cancer
por: Luan, Yang, et al.
Publicado: (2022)

Concordance of MRI-Guided Fusion and Systematic 12-Core Prostate Biopsy for the Detection of Prostate Cancer
por: Parsons, Matthew, et al.
Publicado: (2022)

Bioelectric Impedance Analysis Test Improves the Detection of Prostate Cancer in Biopsy Candidates: A Multifeature Decision Support System
por: Bartoletti, Riccardo, et al.
Publicado: (2021)

Multi-disciplinary and shared decision-making approach in the management of organ-confined prostate cancer
por: Nazim, Syed M., et al.
Publicado: (2018)

MRI/Transrectal Ultrasound Fusion-Guided Targeted Biopsy and Transrectal Ultrasound-Guided Systematic Biopsy for Diagnosis of Prostate Cancer: A Systematic Review and Meta-analysis
por: Xie, Jianfeng, et al.
Publicado: (2022)

Development and Internal Validation of Novel Nomograms Based on Benign Prostatic Obstruction-Related Parameters to Predict the Risk of Prostate Cancer at First Prostate Biopsy
por: Cormio, Luigi, et al.
Publicado: (2018)

Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?
por: Gonvers, Stéphanie, et al.
Publicado: (2022)

Biomarkers in previous histologically negative prostate biopsies can be helpful in repeat biopsy decision‐making processes
por: Long, Xingbo, et al.
Publicado: (2020)

Individualized Decision Making in Transperineal Prostate Biopsy: Should All Men Undergo an Additional Systematic Biopsy?
por: Sigle, August, et al.
Publicado: (2022)

A Pilot Study of (18)F-DCFPyL PET/CT or PET/MRI and Ultrasound Fusion Targeted Prostate Biopsy for Intra-Prostatic PET-Positive Lesions
por: Liu, Yachao, et al.
Publicado: (2021)

Transperineal biopsy of the prostate in a patient post abdominoperineal resection
por: Amin, Amer, et al.
Publicado: (2019)

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
por: Dathathri, Eshwari, et al.
Publicado: (2022)

Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients?
por: Falagario, Ugo Giovanni, et al.
Publicado: (2021)

Prostatectomy versus radiotherapy for early-stage prostate cancer (PREPaRE) study: protocol for a mixed-methods study of treatment decision-making in men with localised prostate cancer
por: Smith, Allan Ben, et al.
Publicado: (2017)

Multiparametric Prostate MRI in Biopsy-Naïve Men: A Prospective Evaluation of Performance and Biopsy Strategies
por: Krüger-Stokke, Brage, et al.
Publicado: (2021)

Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonography
por: Yu, Guo-Peng, et al.
Publicado: (2016)

Prostatic chronic inflammation and prostate cancer risk at baseline random biopsy: Analysis of predictors
por: Tafuri, Alessandro, et al.
Publicado: (2020)

Erratum: Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?
Publicado: (2023)

Combination of PI-RADS score and PSAD can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies
por: Wang, Changming, et al.
Publicado: (2022)

Surveillance prostate biopsy utilizing piflufolastat F 18-PET/CT targeting in the intact prostate – A case report
por: Grossman, Tim, et al.
Publicado: (2023)

The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer
por: Xu, Jianfeng
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h2658ig7vuj42cjrosaog584a0